KJ

Krishna Jaswani

Active Director Director DIN 10339275
DIN 10339275 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value •••• Premium profile

About Krishna Jaswani

Data last updated:

Krishna Jaswani is a Director at Winnexa Health Sciences Private Limited (since 2023). The company operates in Pharma. Winnexa Health Sciences Private Limited reported revenue of ₹7.38 Cr (FY 2025).

DIN 10339275
Primary Designation Director
Industry Pharma
First Appointment 03 Oct 2023
Oldest Company Age 3 yrs
Largest company Winnexa Health Sciences Private Limited · ₹7.38 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Oct 20232023₹7.38 Cr (FY 2025)Active

Board colleagues of Krishna Jaswani

NameDINCompanyDesignation
Bharat Jaswani00436392Winnexa Health Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Winnexa Health Sciences Private Limited
Premium access

Shareholding and investment profile for Krishna Jaswani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Jaswani

Krishna Jaswani currently holds 1 directorship: Winnexa Health Sciences Private Limited (Director, since 03 Oct 2023, revenue ₹7.38 Cr (FY 2025)).

Krishna Jaswani was first appointed on 03 Oct 2023 as Director at Winnexa Health Sciences Private Limited.

The current boards of Krishna Jaswani's companies include Bharat Jaswani (Winnexa Health Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available